ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,308.13
0.09%
Dow Jones
39,806.77
-0.49%
US Dollar vs MXN
16.5706
0.09%
Brent Oil
83.08
-0.54%
Bitcoin
71,299.83
-0.21%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Ovid Therapeutics Inc (OVID)

  7. Ovid Therapeutics Inc (OVID) Noticias

OVID

Ovid Therapeutics (OVID)

Ovid Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:OVID
FechaHoraFuenteTítuloSímboloCompañía
14/05/202416:19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:OVIDOvid Therapeutics Inc
14/05/202407:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OVIDOvid Therapeutics Inc
14/05/202407:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
14/05/202407:00GlobeNewswire Inc.Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial ResultsNASDAQ:OVIDOvid Therapeutics Inc
13/05/202406:00GlobeNewswire Inc.Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor ConferenceNASDAQ:OVIDOvid Therapeutics Inc
04/04/202407:00GlobeNewswire Inc.Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:OVIDOvid Therapeutics Inc
08/03/202407:24Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:OVIDOvid Therapeutics Inc
08/03/202407:00GlobeNewswire Inc.Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:OVIDOvid Therapeutics Inc
28/02/202407:00GlobeNewswire Inc.Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:OVIDOvid Therapeutics Inc
26/02/202417:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OVIDOvid Therapeutics Inc
14/02/202410:10Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OVIDOvid Therapeutics Inc
06/02/202407:00GlobeNewswire Inc.Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:OVIDOvid Therapeutics Inc
01/12/202306:30GlobeNewswire Inc.Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)NASDAQ:OVIDOvid Therapeutics Inc
15/11/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OVIDOvid Therapeutics Inc
15/11/202315:11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OVIDOvid Therapeutics Inc
03/11/202315:08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:OVIDOvid Therapeutics Inc
03/11/202307:00GlobeNewswire Inc.Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate UpdatesNASDAQ:OVIDOvid Therapeutics Inc
18/10/202307:00GlobeNewswire Inc.Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid’s Cash Runway into 2026NASDAQ:OVIDOvid Therapeutics Inc
10/10/202307:00GlobeNewswire Inc.Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro SummitNASDAQ:OVIDOvid Therapeutics Inc
26/09/202306:30GlobeNewswire Inc.Ovid Therapeutics to Host Investor Event - R&D Day on Monday, October 2, 2023NASDAQ:OVIDOvid Therapeutics Inc
20/09/202306:30GlobeNewswire Inc.Ovid Therapeutics to Present at the 2023 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:OVIDOvid Therapeutics Inc
30/08/202307:00GlobeNewswire Inc.Ovid Therapeutics to Participate in Upcoming September Investor ConferencesNASDAQ:OVIDOvid Therapeutics Inc
04/08/202307:00GlobeNewswire Inc.Ovid Therapeutics Reports Second Quarter 2023 Financial Results and Corporate UpdatesNASDAQ:OVIDOvid Therapeutics Inc
01/08/202307:00GlobeNewswire Inc.Ovid Therapeutics to Present at the BTIG Virtual Biotechnology Conference 2023NASDAQ:OVIDOvid Therapeutics Inc
31/07/202316:21Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:OVIDOvid Therapeutics Inc
28/06/202307:00GlobeNewswire Inc.Ovid Therapeutics Expands Its Scientific Leadership Team & Appoints Chief Strategy OfficerNASDAQ:OVIDOvid Therapeutics Inc
26/06/202307:00GlobeNewswire Inc.Ovid Therapeutics Added to Russell 3000® IndexNASDAQ:OVIDOvid Therapeutics Inc
09/06/202307:55Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OVIDOvid Therapeutics Inc
05/05/202316:30Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OVIDOvid Therapeutics Inc
05/05/202308:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OVIDOvid Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:OVID

Su Consulta Reciente

USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
BNPQY
BNP Paribas (QX)
COIN
SOLUSD
Solana
NYSE
NKE
Nike
NYSE
CVX
Chevron
CCOM
US500
US 500
NASDAQ
AAPL
Apple
NYSE
DIS
Walt Disney
FX
USDMXN
US Dollar vs MXN
USOTC
ADDYY
Adidas (QX)
NYSE
VZ
Verizon Communications
NYSE
MRK
Merck
NASDAQ
AMZN
Amazon.com
COIN
ETHUSD
Ethereum
CCOM
SILVER
SILVER
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados